📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
38 announcements match the current filters (relevance ≥ 5).
Halder Venture to Raise ₹25 Crore via Preferential Issue of 7.93 Lakh Warrants at ₹315
Halder Venture Limited is seeking shareholder approval to raise approximately ₹25 crore through the issuance of 7,93,650 convertible warrants to P.K. Bio Link Pvt. Ltd., a non-promoter entity. The warrants are priced at ₹315 each, which includes a premium of ₹305 per share. To facilitate this, the company is also proposing to increase its authorized share capital from ₹13.425 crore to ₹18.425 crore. This capital infusion is intended to support the company's growth and operational needs.
Key Highlights
Proposed issuance of 7,93,650 convertible warrants to non-promoter P.K. Bio Link Pvt. Ltd.
Total fundraise amount fixed at ₹24,99,99,750 at an issue price of ₹315 per warrant.
Authorized share capital to be increased by ₹5 crore to a total of ₹18.425 crore.
Warrant holders must pay 25% of the total consideration upfront, with the remaining 75% due within 18 months upon conversion.
Independent valuation report determined a minimum price of ₹314.79 per equity share, supporting the ₹315 issue price.
👀 What to Watch
The fundraise at a premium suggests confidence from external investors; however, existing shareholders should monitor the potential equity dilution of over 5% upon warrant conversion.
Halder Venture to Raise ₹25 Crore via Preferential Issue of Convertible Warrants
Halder Venture Limited's board has approved a significant fundraise of approximately ₹25 crore through the issuance of 7,93,650 convertible warrants. These warrants are priced at ₹315 each (including a ₹305 premium) and will be allotted to P.K. Bio Link Private Limited, a non-promoter entity. To accommodate this issuance, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the company has transitioned its internal audit function to M/s J Kumar Jain & Associates following the resignation of the previous auditor.
Key Highlights
Approved issuance of 7,93,650 convertible warrants at ₹315 per warrant to raise ₹24.99 crore.
Authorized share capital increased from ₹13.425 crore to ₹18.425 crore to facilitate the issue.
Preferential allotment targeted at a single non-promoter investor, P.K. Bio Link Private Limited.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor for the financial year 2025-2026.
The fundraise and capital increase are subject to shareholder approval via postal ballot.
👀 What to Watch
Investors should view the ₹25 crore capital infusion as a positive indicator for growth and monitor the company's upcoming postal ballot for shareholder approval. The warrant pricing at ₹315 serves as a key valuation benchmark for the stock.
Halder Venture to Raise ₹25 Crore via Preferential Issue of 7.93 Lakh Warrants
Halder Venture Limited has approved the issuance of 7,93,650 convertible warrants to P.K. Bio Link Private Limited, a non-promoter entity, at a price of ₹315 per warrant. This preferential allotment aims to raise approximately ₹25 crore, subject to shareholder approval via postal ballot. To facilitate this, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the board has appointed M/s J Kumar Jain & Associates as the new internal auditor following the resignation of the previous firm.
Key Highlights
Approved issuance of 7,93,650 convertible warrants at ₹315 per warrant (including ₹305 premium).
Total fundraise amount is approximately ₹24,99,99,750 from a non-promoter entity.
Authorised share capital increased from ₹13.425 crore to ₹18.425 crore.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor for FY 2025-26.
Warrants are convertible into one fully paid-up equity share of ₹10 face value each.
👀 What to Watch
Investors should monitor the specific purpose of the ₹25 crore fundraise and the potential equity dilution upon warrant conversion. The pricing of ₹315 per warrant serves as a key valuation benchmark for the company.
Halder Venture to Raise ₹25 Crore via Preferential Issue of 7.94 Lakh Convertible Warrants
Halder Venture Limited has approved a significant fundraise of approximately ₹25 crore through the preferential allotment of 7,93,650 convertible warrants to P.K. Bio Link Private Limited, a non-promoter entity. The warrants are priced at ₹315 each, representing a substantial premium over the ₹10 face value. To accommodate this and future requirements, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. The board also transitioned its internal audit function to M/s J Kumar Jain & Associates following the resignation of the previous auditor.
Key Highlights
Approved issuance of 7,93,650 convertible warrants at a price of ₹315 per warrant (including ₹305 premium).
Total capital to be raised through the preferential issue is approximately ₹24.99 crore.
Authorised share capital increased from ₹13.425 crore to ₹18.425 crore to facilitate the issuance.
P.K. Bio Link Private Limited identified as the sole non-promoter investor for this round.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor for the financial year 2025-2026.
👀 What to Watch
Investors should track the shareholder approval via postal ballot and the subsequent utilization of the ₹25 crore proceeds for growth initiatives. While the fundraise is positive, be mindful of the eventual equity dilution when warrants are converted.
Halder Venture to Raise ₹25 Crore via Preferential Issue of Convertible Warrants
Halder Venture Limited has approved a fundraise of approximately ₹25 crore through the issuance of 7,93,650 convertible warrants on a preferential basis. The warrants are priced at ₹315 each, including a premium of ₹305, and will be allotted to a non-promoter entity, P.K. Bio Link Private Limited. To accommodate this and future requirements, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the board has appointed M/s J Kumar Jain & Associates as the new internal auditor for FY 2025-26.
Key Highlights
Approved issuance of 7,93,650 convertible warrants at a price of ₹315 per warrant.
Total fundraise amount is approximately ₹25 crore (₹24,99,99,750) from a non-promoter investor.
Authorized share capital increased from ₹13.425 crore to ₹18.425 crore.
Each warrant is convertible into one fully paid-up equity share of ₹10 face value.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor following the resignation of the previous firm.
👀 What to Watch
Investors should view the capital infusion as a positive sign for growth, though they should be mindful of the eventual equity dilution upon warrant conversion. Monitor the upcoming postal ballot results for shareholder approval of these resolutions.
Halder Venture to Raise ₹25 Crore via Preferential Issue of 7.93 Lakh Warrants
Halder Venture Limited has approved a significant fundraise of approximately ₹25 crore through the preferential issuance of 7,93,650 convertible warrants. These warrants are priced at ₹315 each, which includes a substantial premium of ₹305 per share, and will be allotted to a non-promoter entity, P.K. Bio Link Private Limited. To accommodate this issuance, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. The board also transitioned its internal audit firm to M/s J Kumar Jain & Associates following the resignation of the previous auditor.
Key Highlights
Approved issuance of 7,93,650 convertible warrants at a price of ₹315 per warrant
Total capital infusion of approximately ₹24,99,99,750 from non-promoter investor P.K. Bio Link Private Limited
Authorized share capital increased by ₹5 crore to reach a new limit of ₹18.425 crore
Appointment of M/s J Kumar Jain & Associates as Internal Auditor for FY 2025-26
Warrants are convertible into equity shares on a 1:1 basis subject to shareholder approval via postal ballot
👀 What to Watch
Investors should view the capital raise at a premium as a positive signal for growth, though they should monitor the eventual equity dilution upon warrant conversion. Watch for further disclosures regarding the specific end-use of these funds.
Halder Venture to Raise ₹25 Crore via Preferential Issue of 7.93 Lakh Convertible Warrants
Halder Venture Limited has approved a significant fundraise of approximately ₹25 crore through the issuance of 7,93,650 convertible warrants to a non-promoter entity, P.K. Bio Link Private Limited. The warrants are priced at ₹315 each, which includes a premium of ₹305 over the face value. To accommodate this issuance, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the board has appointed M/s J Kumar Jain & Associates as the new internal auditor for FY 2025-26.
Key Highlights
Issuance of 7,93,650 convertible warrants at a price of ₹315 per warrant.
Total fundraise amount stands at approximately ₹24,99,99,750 from a non-promoter investor.
Authorized share capital increased by ₹5 crore to a new total of ₹18.42,50,000.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor following the resignation of M/s Somnath Ray & Associates.
The warrant issuance and capital increase are subject to shareholder approval via postal ballot.
👀 What to Watch
Investors should track the shareholder approval process and the eventual conversion of these warrants into equity, which will result in some dilution but provides growth capital. The pricing of ₹315 per warrant serves as a key valuation benchmark for the company.
Halder Venture to Raise ₹25 Crore via Warrants; Increases Authorised Capital to ₹18.42 Crore
Halder Venture Limited has approved a significant fundraise of approximately ₹25 crore through the preferential issuance of 7,93,650 convertible warrants to a non-promoter entity, P.K. Bio Link Private Limited. To accommodate this and future requirements, the company is increasing its authorised share capital from ₹13.42 crore to ₹18.42 crore. The warrants are priced at ₹315 each, representing a substantial premium of ₹305 over the face value. Additionally, the company has appointed M/s J Kumar Jain & Associates as the new internal auditor for FY 2025-26.
Key Highlights
Approved issuance of 7,93,650 convertible warrants at ₹315 per warrant, totaling ₹24.99 crore.
Authorised share capital increased by ₹5 crore to a new total of ₹18.425 crore.
Preferential allotment is being made to a non-promoter investor, P.K. Bio Link Private Limited.
Warrant conversion price includes a premium of ₹305 per share on a face value of ₹10.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor following the resignation of the previous firm.
👀 What to Watch
Investors should view the fundraise at a significant premium as a positive indicator of valuation and growth potential. Monitor the upcoming postal ballot results for shareholder approval and subsequent updates on the utilization of these funds.
Halder Venture to Raise ₹25 Crore via Preferential Issue of 7.93 Lakh Convertible Warrants
Halder Venture Limited has approved a significant fundraise of approximately ₹25 crore through the issuance of 7,93,650 convertible warrants to a non-promoter entity, P.K. Bio Link Private Limited. The warrants are priced at ₹315 each, representing a substantial premium over the ₹10 face value. To accommodate this issuance and future requirements, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the company has transitioned its internal auditor to M/s J Kumar Jain & Associates for the 2025-26 financial year.
Key Highlights
Issuance of 7,93,650 convertible warrants at a price of ₹315 per warrant (including ₹305 premium).
Total capital to be raised amounts to approximately ₹24,99,99,750 from a non-promoter investor.
Authorized share capital increased from ₹13.425 crore to ₹18.425 crore, a ₹5 crore expansion.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor following the resignation of the previous firm.
👀 What to Watch
Investors should view the capital infusion at a premium as a positive signal of valuation support, though they should remain mindful of future equity dilution upon warrant conversion. Monitor the company's subsequent disclosures regarding the specific utilization of these funds for growth initiatives.
Halder Venture to Raise ₹25 Crore via Convertible Warrants; Increases Authorised Capital
Halder Venture Limited has approved a significant fundraise of approximately ₹25 crore through the issuance of 7,93,650 convertible warrants to a non-promoter entity, P.K. Bio Link Private Limited. The warrants are priced at ₹315 each, which includes a substantial premium of ₹305 per share. To accommodate this and future growth, the board has also proposed increasing the company's authorised share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the company has appointed M/s J Kumar Jain & Associates as the new Internal Auditor following a resignation.
Key Highlights
Approved issuance of 7,93,650 convertible warrants at ₹315 per warrant to raise ₹24,99,99,750.
Authorised share capital increased from ₹13.425 crore to ₹18.425 crore, adding 50 lakh new equity shares.
Warrants are allotted to P.K. Bio Link Private Limited, a non-promoter investor.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor for FY 2025-26.
Fundraise and capital increase are subject to shareholder approval via postal ballot.
👀 What to Watch
Investors should view the fundraise at a premium as a positive sign of valuation support, though they should monitor the eventual equity dilution upon warrant conversion. Watch for further disclosures regarding the specific end-use of the ₹25 crore capital infusion.
Halder Venture to Raise ₹25 Crore via Warrants; Increases Authorised Capital
Halder Venture Limited has approved a preferential issue of 7,93,650 convertible warrants to P.K. Bio Link Private Limited, a non-promoter entity, to raise approximately ₹25 crore. The warrants are priced at ₹315 each, which includes a substantial premium of ₹305 over the face value of ₹10. To facilitate this and future expansions, the board has also proposed increasing the authorized share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the company has appointed M/s J Kumar Jain & Associates as the new internal auditor following the resignation of the previous firm.
Key Highlights
Proposed issuance of 7,93,650 convertible warrants at ₹315 per warrant to raise ₹24.99 crore.
Increase in authorized share capital by ₹5 crore to a new total of ₹18.425 crore.
Warrants are convertible into equity shares on a 1:1 basis, subject to shareholder approval via postal ballot.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor for the financial year 2025-2026.
The fundraise is directed toward a non-promoter investor, potentially diversifying the stakeholder base.
👀 What to Watch
The capital infusion at a significant premium is a positive indicator of external confidence in the company's valuation. Investors should monitor the upcoming postal ballot results and the company's subsequent plans for utilizing the ₹25 crore proceeds.
Halder Venture to Raise ₹25 Crore via Preferential Issue of 7.93 Lakh Warrants
Halder Venture Limited has approved a significant fundraise of approximately ₹25 crore through the preferential allotment of 7,93,650 convertible warrants to P.K. Bio Link Private Limited. The warrants are priced at ₹315 each, representing a substantial premium over the ₹10 face value. To accommodate this issuance, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the board has appointed M/s J Kumar Jain & Associates as the new Internal Auditor following the resignation of the previous firm.
Key Highlights
Approved issuance of 7,93,650 convertible warrants at a price of ₹315 per warrant (including ₹305 premium).
Total capital to be raised amounts to approximately ₹24,99,99,750 from a non-promoter entity.
Authorized Share Capital increased by ₹5 crore, from ₹13.425 crore to ₹18.425 crore.
Appointment of M/s J Kumar Jain & Associates as Internal Auditor for the Financial Year 2025-2026.
The fundraise and capital changes are subject to shareholder approval via Postal Ballot.
👀 What to Watch
Investors should view the capital infusion as a positive sign for growth, though they should monitor the eventual equity dilution when warrants are converted. The pricing of ₹315 per warrant serves as a key valuation benchmark for the stock.
Halder Venture to Consider Fundraising via Preferential Issue on March 26, 2026
Halder Venture Limited has scheduled a Board Meeting for March 26, 2026, to deliberate on two major corporate actions. The primary agenda includes a proposal for raising funds through a preferential issue of securities, which often signals expansion or debt reduction. Additionally, the board will consider an increase in the company's authorized share capital to facilitate this issuance. Investors should note that the trading window for insiders has been closed effective March 26 until 48 hours after the meeting results are disclosed.
Key Highlights
Board meeting scheduled for March 26, 2026, to approve fundraising via preferential issue.
Proposal to increase the authorized share capital of the company to be discussed.
Trading window for promoters and designated persons closed from March 26, 2026.
The meeting is set to take place at the company's Kolkata office at 3:00 P.M.
👀 What to Watch
Investors should wait for the board meeting outcome to understand the quantum of funds being raised and the issue price. A preferential issue to strategic investors can be a positive catalyst, though it may lead to equity dilution.
Halder Venture Q3 Profit Falls YoY; Announces ₹30.16 Cr Acquisition of Inqube Technologies
Halder Venture Limited reported a standalone net profit of ₹2.17 crore for Q3 FY26, a sharp decline from ₹13.45 crore in the same quarter last year, though it showed sequential improvement from Q2. The company has approved a strategic acquisition of a 52% stake in Inqube Technologies for ₹30.16 crore to diversify into Agri-ERP and carbon credit markets. Operationally, the company has started packaging at its Haldia unit, capitalizing ₹22.45 crore. However, auditors have raised concerns regarding a pending ₹6.05 crore dividend from a foreign subsidiary that remains uncollected.
Key Highlights
Standalone Net Profit for Q3 FY26 at ₹2.17 crore, down 83.8% YoY from ₹13.45 crore.
Approved acquisition of 52% stake in Inqube Technologies Private Limited for ₹30.16 crores.
Revenue from operations fell to ₹73.63 crore in Q3 FY26 from ₹286.97 crore in Q3 FY25.
Capitalized ₹22.45 crore following the operationalization of packaging units at the Haldia Manufacturing Unit.
Auditors highlighted a potential impairment risk for ₹6.05 crore in dividend income receivable from a foreign subsidiary.
👀 What to Watch
Investors should closely monitor the execution of the Inqube acquisition and the recovery of the ₹6.05 crore dividend from the foreign subsidiary. While the YoY earnings drop is concerning, the operationalization of the Haldia unit and the new tech-focused acquisition are key long-term growth drivers to track.
Halder Venture Fined ₹5.43 Lakh by BSE for Board Composition Non-Compliance
Halder Venture Limited has been penalized ₹5,42,800 by BSE for failing to comply with SEBI Regulation 17(1) regarding board composition during the September 2025 quarter. The company explained that the lapse occurred during the transition period following an amalgamation that made corporate governance norms applicable. Management confirmed that the company became fully compliant on November 14, 2025, and has since filed a waiver application with the exchange. The Board has reviewed the matter and advised the management to exercise abundant caution to ensure future regulatory adherence.
Key Highlights
BSE imposed a total fine of ₹5,42,800 (including ₹82,800 GST) for non-compliance with Regulation 17(1).
The company achieved full compliance with board composition requirements on November 14, 2025.
A waiver application for the levied fine was filed with BSE on December 1, 2025.
The regulatory lapse followed a Scheme of Amalgamation that became effective on January 1, 2025.
👀 What to Watch
Investors should note the governance lapse but also recognize that the company has already rectified the board composition. Monitor the outcome of the waiver application and ensure no further regulatory delays occur in future filings.
Halder Venture to Acquire 52% Stake in Inqube Technologies for ₹30.16 Crores
Halder Venture Limited has approved the acquisition of a 52% controlling stake in Inqube Technologies Private Limited for ₹30.16 crores, aimed at integrating cloud-based Agri-ERP solutions and entering the carbon credits market. For the quarter ended December 31, 2025, the company reported standalone revenue of ₹73.63 crores and a net profit of ₹2.17 crores. The company also operationalized its Haldia packaging unit, capitalizing ₹22.45 crores in the process. However, auditors highlighted a pending dividend of ₹6.05 crores from a foreign subsidiary that remains uncollected.
Key Highlights
Acquisition of 52% stake in Inqube Technologies for ₹30.16 crores to be completed in tranches over 24 months.
Standalone Q3 FY26 revenue reported at ₹7,363.09 lakhs with a net profit of ₹217.10 lakhs.
Capitalized ₹2,244.57 lakhs following the operationalization of packaging units at the Haldia Manufacturing facility.
Auditors flagged a delay in receiving ₹605.07 lakhs dividend income from foreign subsidiary Hal Exim Pte Limited.
Strategic entry into carbon credit commercialization and tech-driven agricultural value chain efficiency.
👀 What to Watch
Investors should monitor the successful integration of Inqube's tech platform and the timely repatriation of the ₹6.05 crore dividend from the foreign subsidiary. The operationalization of the Haldia unit is a positive sign for future production capacity.
Halder Venture Q3 Net Profit Jumps 105% YoY to ₹2.17 Cr; Announces 52% Stake Buy in InQube
Halder Venture reported a robust performance for Q3 FY26, with standalone revenue growing 28.8% YoY to ₹73.63 crore and net profit doubling to ₹2.17 crore. The company is aggressively expanding, having operationalized its Haldia Manufacturing Unit and announcing a ₹30.16 crore acquisition of a 52% stake in InQube Technologies to enter the Agri-ERP and carbon credit markets. However, investors should monitor an auditor's emphasis regarding a delayed ₹6.05 crore dividend from a foreign subsidiary. For the nine-month period, net profit stands significantly higher at ₹13.45 crore compared to ₹7.15 crore in the previous year.
Key Highlights
Standalone Net Profit for Q3 FY26 surged 105% YoY to ₹217.10 lakhs from ₹105.76 lakhs.
Revenue from operations increased by 28.8% YoY to ₹7,363.09 lakhs compared to ₹5,716.92 lakhs.
Approved acquisition of 52% stake in InQube Technologies for ₹3,016 lakhs to enter Agri-ERP and carbon credit sectors.
Capitalized ₹2,244.57 lakhs for packaging operations at the Haldia Manufacturing Unit during the quarter.
Auditor raised an emphasis of matter regarding ₹605.07 lakhs in delayed dividend income from a foreign subsidiary.
👀 What to Watch
The strong earnings growth and strategic diversification into agri-tech are positive indicators, but investors should seek clarity on the recoverability of the ₹6.05 crore foreign dividend highlighted by auditors.
Halder Venture Q3 Profit Doubles to ₹2.17 Cr; Acquires 52% Stake in Inqube for ₹30.16 Cr
Halder Venture reported a strong performance for Q3 FY26, with revenue from operations reaching ₹7,363.09 lakhs compared to ₹5,716.92 lakhs in the same quarter last year. The company's net profit more than doubled to ₹217.10 lakhs from ₹105.76 lakhs YoY. Additionally, the board approved a strategic acquisition of a 52% stake in Inqube Technologies for ₹30.16 crores to enter the Agri-ERP and carbon credit markets. However, investors should note an auditor's observation regarding a delayed dividend of ₹605.07 lakhs from a foreign subsidiary.
Key Highlights
Revenue from operations grew to ₹7,363.09 lakhs in Q3 FY26 from ₹5,716.92 lakhs in Q3 FY25.
Net profit for the quarter increased by 105% YoY to ₹217.10 lakhs.
Board approved 52% stake acquisition in Inqube Technologies for ₹30.16 crores to be completed within 24 months.
Capitalized ₹2,244.57 lakhs following the operationalization of packaging units at the Haldia facility.
Auditors highlighted a pending dividend receivable of ₹605.07 lakhs from a foreign subsidiary, though management claims it is not credit impaired.
👀 What to Watch
Investors should view the strong earnings growth and tech-focused acquisition as positive long-term drivers. Monitor the recovery of the ₹6.05 crore dividend from the foreign subsidiary as highlighted by auditors to ensure no future impairments.
